https://www.selleckchem.com/products/apd334.html
These studies lay the foundation for epigenetic-directed therapy in ENKTL. Through epigenetic and transcriptomic analyses of ENKTL, a rare, aggressive malignancy, along with normal NK-cell developmental intermediates, we identified that extreme DNA hypermethylation targets genes required for NK-cell development. Disrupting this epigenetic blockade in novel PDX models led to ENKTL differentiation and improved survival. This article is highlighted in the In This Issue feature, p. 85. Through epigenetic and transcriptomic analyses of ENKTL,
Like
Comment
Share
